» Articles » PMID: 37505372

Hype or Hope? A Review of Challenges in Balancing Tumor Control and Treatment Toxicity in Breast Cancer from the Perspective of the Radiation Oncologist

Overview
Specialty Oncology
Date 2023 Jul 28
PMID 37505372
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this article is to discuss the challenges and new strategies in managing breast cancer patients, with a specific focus on radiation oncology and the importance of balancing oncologic outcomes with quality of life and post-treatment morbidity. A comprehensive literature review was conducted to identify advances in the management of breast cancer, exploring de-escalation strategies, hypofractionation schemes, predictors and tools for reducing toxicity (radiation-induced lymphocyte apoptosis, deep inspiration breath-hold, adaptive radiotherapy), enhancer treatments (hyperthermia, immunotherapy) and innovative diagnostic modalities (PET-MRI, omics). Balancing oncologic outcomes with quality of life and post-treatment morbidity is crucial in the era of personalized medicine. Radiotherapy plays a critical role in the management of breast cancer patients. Large randomized trials are necessary to generalize some practices and cost remains the main obstacle for many innovations that are already applicable.

References
1.
Hong R, Xu B . Breast cancer: an up-to-date review and future perspectives. Cancer Commun (Lond). 2022; 42(10):913-936. PMC: 9558690. DOI: 10.1002/cac2.12358. View

2.
Offersen B, Alsner J, Nielsen H, Jakobsen E, Nielsen M, Krause M . Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial. J Clin Oncol. 2020; 38(31):3615-3625. DOI: 10.1200/JCO.20.01363. View

3.
Whelan T, Pignol J, Levine M, Julian J, MacKenzie R, Parpia S . Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010; 362(6):513-20. DOI: 10.1056/NEJMoa0906260. View

4.
Meattini I, Becherini C, Boersma L, Kaidar-Person O, Marta G, Montero A . European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer. Lancet Oncol. 2022; 23(1):e21-e31. DOI: 10.1016/S1470-2045(21)00539-8. View

5.
Meattini I, Guenzi M, Fozza A, Vidali C, Rovea P, Meacci F . Overview on cardiac, pulmonary and cutaneous toxicity in patients treated with adjuvant radiotherapy for breast cancer. Breast Cancer. 2016; 24(1):52-62. DOI: 10.1007/s12282-016-0694-3. View